2-es típusú cukorbetegség: vizsgálatok itt: Lengyelország
39 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 2026. november 18.. Ask the study team whether a trial fits you.
- 3. fázisNot yet taking people in LengyelországA Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, Type 2 Diabetes, and Increased Cardiovascular Risk
- Where
- Bialystok, Białystok, Krakow, Kraków, Lublin, Piotrkow Trybunalski
- Életkor
- 45 év to 64 év
- People
- 3000 worldwide
- Run by
- Eli Lilly and Company
See details and how to joinNCT07900633 · EU 2026-525919-14-00 - 3. fázisTaking peopleEASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease
- Where
- Belchatow, Bialystok, Bydgoszcz, Chojnice, Cracow, Częstochowa, Elblag, Gdynia, Katowice, Lodz, Olsztyn, Opole, Staszow, Warsaw, Wroclaw
- Életkor
- 18 év and over
- People
- 11 800 worldwide
- Run by
- Boehringer Ingelheim
See details and how to joinNCT07064473 · EU 2025-521188-11-00 - 2. fázisFut, nem toborozA Study to Compare Different Doses of Tifeglipron (RO7795081) With Placebo or Semaglutide in People With Type 2 Diabetes
- Where
- Białystok, Bydgoszcz, Gdansk, Katowice, Lublin, Tarnów, Warsaw, Wroclaw, Zamość
- Életkor
- 18 év and over
- People
- 330 worldwide
- Run by
- Hoffmann-La Roche
See details and how to joinNCT07112872 · EU 2024-520322-11-00 - 3. fázisNot yet taking people in LengyelországA Research Study Investigating How Well Zenagamtide Lowers Blood Sugar and Body Weight Compared to Placebo in People With Type 2 Diabetes Treated With Diet and Exercise
- Where
- Katowice, Malbork, Oswiecim, Plock, Staszow, Świnoujście, Warsaw
- Életkor
- 18 év and over
- People
- 200 worldwide
- Run by
- Novo Nordisk A/S
See details and how to joinNCT07931495 · EU 2026-525470-18-00 - 3. fázisTaking peopleA Research Study Investigating How Well Zenagamtide Lowers Blood Sugar and Body Weight Compared to Placebo in People With Type 2 Diabetes and Chronic Kidney Disease Treated With Once Daily Basal Insulin Alone or in Combination With Metformin, SGLT2i, or Both
- Where
- Chorzów, Gdansk, Lublin, Olsztyn, Oswiecim, Swiecie, Warsaw, Zabrze
- Életkor
- 18 év and over
- People
- 450 worldwide
- Run by
- Novo Nordisk A/S
See details and how to joinNCT07931547 · EU 2026-525471-13-00 - 3. fázisTaking peopleAMBITION 3: A Research Study Investigating How Well Zenagamtide at Higher Dose Levels Lowers Blood Sugar and Body Weight Compared to Semaglutide in People With Type 2 Diabetes Treated With Metformin, SGLT2i, or Both
- Where
- Bialystok, Chojnice, Lublin, Piotrkow Trybunalski, Tarnów, Warsaw, Wrocław, Zabrze
- Életkor
- 18 év and over
- People
- 1200 worldwide
- Run by
- Novo Nordisk A/S
See details and how to joinNCT07931573 · EU 2026-525472-26-00 - 3. fázisTaking peopleA Research Study Investigating How Well Zenagamtide at Lower Dose Levels Lowers Blood Sugar and Body Weight Compared to Semaglutide at Lower Dose Levels in People With Type 2 Diabetes Treated With Metformin, Sodium-Glucose Cotransporter 2 Inhibitors (SGLT2i), or Both
- Where
- Cracow, Leczna, Malbork, Skierniewice, Sosnowiec
- Életkor
- 18 év and over
- People
- 1060 worldwide
- Run by
- Novo Nordisk A/S
See details and how to joinNCT07931599 · EU 2026-525474-20-00 - No phaseTaking peopleType 2 Diabetes and Pregnancy a Single-arm Interventional Study
- Where
- Poznan
- Életkor
- 18 év to 45 év
- People
- 20
- Run by
- Poznan University of Medical Sciences
See details and how to joinNCT07602036 - 3. fázisFut, nem toborozA Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight Without Type 2 Diabetes
- Where
- Bialystok, Bydgoszcz, Cracow, Gdynia, Lublin, Opole, Tarnów, Tychy, Warsaw, Zamość
- Életkor
- 18 év and over
- People
- 2000 worldwide
- Run by
- Hoffmann-La Roche
See details and how to joinNCT07351045 · EU 2025-523104-71-00 - 3. fázisTaking peopleA Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight and Type 2 Diabetes
- Where
- Białystok, Bydgoszcz, Debica, Lublin, Pabianice, Poznan, Ruda Śląska, Siedlce, Warsaw, Wroclaw
- Életkor
- 18 év and over
- People
- 1600 worldwide
- Run by
- Hoffmann-La Roche
See details and how to joinNCT07351058 · EU 2025-523106-32-00 - 3. fázisFut, nem toborozA Study to Learn About the Study Medicine Called Berobenatide (PF-08653944) in People With Overweight or Obesity
- Where
- Gdansk, Lublin, Poznan, Wrocław, ZDROWIE OSTEO-MEDIC S.C. L. i A. Racewicz, A. i J. Supronik
- Életkor
- 18 év and over
- People
- 954 worldwide
- Run by
- Pfizer
See details and how to joinNCT07595549 · EU 2026-525318-75-00 - 3. fázisNot yet taking people in LengyelországA Phase III Study to Evaluate the Efficacy and Safety of Petrelintide in Participants With Overweight or Obesity and Type 2 Diabetes
- Where
- Bialystok, Cracow, Mazowieckie, Warsaw
- Életkor
- 18 év and over
- People
- 600 worldwide
- Run by
- Hoffmann-La Roche
See details and how to joinNCT07843485 · EU 2026-526189-25-00 - No phaseTaking peopleContinuous Glucose Monitoring Systems in People With Type 2 Diabetes Not Treated With Insulin
- Where
- Bialystok
- Életkor
- 18 év to 65 év
- People
- 50
- Run by
- Medical University of Bialystok
See details and how to joinNCT07919236 - 2. fázisFut, nem toborozA Study of LY3457263 Compared With Placebo in Participants With Type 2 Diabetes on a Stable Dose of Semaglutide or Tirzepatide
- Where
- Bialystok, Cracow, Gdansk, Lodz, Lublin, Tarnów, Warsaw, Warszawa, Wroclaw
- Életkor
- 18 év to 75 év
- People
- 200 worldwide
- Run by
- Eli Lilly and Company
See details and how to joinNCT06897475 · EU 2024-520328-27-00 - 3. fázisTaking peopleA Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, and Type 2 Diabetes
- Where
- Bialystok, Bydgoszcz, Cracow, Elblag, Lodz, Lublin, Ruda Śląska, Zabrze
- Életkor
- 18 év and over
- People
- 1035 worldwide
- Run by
- Eli Lilly and Company
See details and how to joinNCT07282600 · EU 2025-523658-15-00 - 3. fázisTaking peopleA Phase III Study to Investigate the Efficacy and Safety of the Combination of Elecoglipron and Dapagliflozin in Adults With Type 2 Diabetes Mellitus
- Where
- Bialystok, Częstochowa, Kielce, Lodz, Lublin, Poznan, Radom, Warsaw
- Életkor
- 18 év and over
- People
- 2000 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT07662109 · EU 2025-523941-81-00 - 3. fázisTaking peopleA Study to Evaluate Effect of AZD6234 in Adult Participants With Obesity or Overweight With Weight-related Comorbidity Without Type 2 Diabetes Mellitus
- Where
- Bialystok, Cracow, Elblag, Gdynia, Katowice, Legnica, Lodz, Poznan, Radzionkow, Warsaw, Wroclaw
- Életkor
- 18 év and over
- People
- 2500 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT07784725 · EU 2025-523379-41-00 - 3. fázisNot yet taking people in LengyelországA Study to Evaluate Effect of AZD6234 in Adult Participants With Type 2 Diabetes Mellitus and Obesity or Overweight
- Where
- Bialystok, Elblag, Gdynia, Katowice, Krakow, Legnica, Lodz, Poznan, Radzionków, Warsaw, Wroclaw
- Életkor
- 18 év and over
- People
- 1500 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT07784270 - No phaseTaking peopleClinical Study to Evaluate the Impact of the Accu-Chek SmartGuide CGM Solution on the Mean Change in Time in Range Compared With Self-Monitoring of Blood Glucose in Participants With Type 1 and Type 2 Diabetes Mellitus
- Where
- Gdansk, Krakow, Kraśnik, Lublin, Nadarzyn, Warsaw
- Életkor
- 18 év and over
- People
- 270 worldwide
- Run by
- Hoffmann-La Roche
See details and how to joinNCT06704672 - 3. fázisTaking peopleA Study to Find Out if the Study Drug Elecoglipron Helps Adults With Type 2 Diabetes Mellitus by Comparing it With Semaglutide, a Medicine Already Used to Treat Type 2 Diabetes Mellitus
- Where
- Bialystok, Cracow, Lodz, Lublin, Poznan, Radom, Warsaw
- Életkor
- 18 év and over
- People
- 1200 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT07662213 · EU 2025-523933-24-00 - 3. fázisTaking peopleEfficacy and Safety of Once-Daily Oral ASC30 Compared with Placebo in Participants with Obesity or Overweight with Type 2 Diabetes Mellitus
- Where
- Biała Podlaska, Bydgoszcz, Cracow, Czestochowa, Gdansk, Gdynia, Katowice, Krakow, Lodz, Łódź, Lublin, Poznan, Pulawy, Siedlce, Staszow, Torun, Warsaw, Warszawa, Wroclaw, Wrocław
- Életkor
- 18 év and over
- People
- 549 worldwide
- Run by
- Ascletis Pharma (China) Co. Ltd.
See details and how to join2026-526336-39-00 - 3. fázisTaking peopleA Master Protocol to Investigate Efficacy and Safety of Elecoglipron in Participants With Obesity or Overweight With or Without T2DM
- Where
- Bialystok, Bydgoszcz, Kielce, Krakow, Lodz, Lublin, Poznan, Radom, Warsaw
- Életkor
- 18 év and over
- People
- 4500 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT07667803 - 3. fázisTaking peopleA Study to evaluate effect of AZD6234 in adult participants with Type 2 Diabetes Mellitus and obesity or overweight
- Where
- Bialystok, Cracow, Elblag, Gdynia, Katowice, Legnica, Lodz, Poznan, Radzionkow, Warsaw, Wroclaw
- Életkor
- 18 év and over
- People
- 420 worldwide
- Run by
- AstraZeneca AB
See details and how to join2025-524616-11-00 - 2. fázisTaking peopleA Research Study Comparing How Well Different Doses of the Medicine UBT251 Lower Blood Sugar in People With Type 2 Diabetes
- Where
- Bialystok, Białystok, Kielce, Lublin, Oswiecim
- Életkor
- 18 év to 75 év
- People
- 300 worldwide
- Run by
- Novo Nordisk A/S
See details and how to joinNCT07668388 · EU 2026-525465-42-00 - 4. fázisTaking peoplePancreatin Added to Standard Antihyperglycemic Therapy in Patients With Type 2 Diabetes
- Where
- Zabrze
- Életkor
- 35 év to 75 év
- People
- 100
- Run by
- Silesian Centre for Heart Diseases
See details and how to joinNCT07852988